Taliglucerase Alfa Patent Expiration

1. Elelyso patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8741620 PFIZER Human lysosomal proteins from plant cell culture
Feb, 2024

(4 months ago)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8227230 PFIZER Human lysosomal proteins from plant cell culture
Feb, 2024

(4 months ago)

US8790641 PFIZER Production of high mannose proteins in plant culture and therapeutic uses thereof
Oct, 2025

(1 year, 3 months from now)




Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) May 01, 2017
New Patient Population(NPP) Aug 27, 2017

NCE-1 date: 01 May, 2016

Market Authorisation Date: 01 May, 2012

Treatment: A method of catalyzing the hydrolysis of glucocerebroside to glucose and ceramide.

Dosage: POWDER

More Information on Dosage

ELELYSO family patents

Family Patents